BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31780193)

  • 1. Determining patient preferences of community pharmacy attributes: A systematic review.
    Patel PM; Vaidya V; Osundina F; Comoe DA
    J Am Pharm Assoc (2003); 2020; 60(2):397-404. PubMed ID: 31780193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient preferences for objective quality metrics during community pharmacy selection: A discrete choice experiment.
    Patterson JA; Holdford DA; Harpe SE
    Res Social Adm Pharm; 2019 Jun; 15(6):641-649. PubMed ID: 30143466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Minor Ailments; The Public's Preferences for Attributes of Community Pharmacies. A Discrete Choice Experiment.
    Porteous T; Ryan M; Bond C; Watson M; Watson V
    PLoS One; 2016; 11(3):e0152257. PubMed ID: 27031588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient preferences for community pharmacy asthma services: a discrete choice experiment.
    Naik-Panvelkar P; Armour C; Rose JM; Saini B
    Pharmacoeconomics; 2012 Oct; 30(10):961-76. PubMed ID: 22823521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacy patronage: identifying key factors in the decision making process using the determinant attribute approach.
    Franic DM; Haddock SM; Tucker LT; Wooten N
    J Am Pharm Assoc (2003); 2008; 48(1):71-85. PubMed ID: 18192134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacists' role in caring for people living with epilepsy: A scoping review.
    Bacci JL; Zaraa S; Stergachis A; Simic G; White HS
    Epilepsy Behav; 2021 Apr; 117():107850. PubMed ID: 33631435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient Preferences For Specialty Pharmacy Services: A Stated Preference Discrete-Choice Experiment in China.
    Hu Q; Hu H; Hu M; Yang Y; Wu Z; Zhou N
    Front Public Health; 2020; 8():597389. PubMed ID: 33363089
    [No Abstract]   [Full Text] [Related]  

  • 8. Medication review service implementation in community pharmacy settings: Scoping review with focus on implementation studies.
    Brandt J; Lê ML; Jantscher S; Bricelj A; Louizos C; Ng S; Sibley K
    Res Social Adm Pharm; 2020 Jul; 16(7):875-885. PubMed ID: 31606298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist's Demand for Optimal Primary Care Service Delivery in a Community Pharmacy: The OPTiPharm Study.
    Munger MA; Walsh M; Godin J; Feehan M
    Ann Pharmacother; 2017 Dec; 51(12):1069-1076. PubMed ID: 28737045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes, costs and stakeholders' perspectives associated with the incorporation of community pharmacy services into the National Health Insurance System in Thailand: a systematic review.
    Asayut N; Sookaneknun P; Chaiyasong S; Saramunee K
    Int J Pharm Pract; 2018 Feb; 26(1):16-27. PubMed ID: 28795519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences of patients regarding community pharmacy services: A discrete choice experiment.
    van de Pol JM; Heringa M; Koster ES; Bouvy ML
    Health Policy; 2021 Nov; 125(11):1415-1420. PubMed ID: 34503844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National survey of pharmacy-based immunization services.
    Westrick SC; Patterson BJ; Kader MS; Rashid S; Buck PO; Rothholz MC
    Vaccine; 2018 Sep; 36(37):5657-5664. PubMed ID: 30049631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of patients' demand for community pharmacies: relationship between pharmacy services and patient satisfaction.
    Kamei M; Teshima K; Fukushima N; Nakamura T
    Yakugaku Zasshi; 2001 Mar; 121(3):215-20. PubMed ID: 11265116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review in select countries of the role of the pharmacist in consultations and sales of non-prescription medicines in community pharmacy.
    van Eikenhorst L; Salema NE; Anderson C
    Res Social Adm Pharm; 2017; 13(1):17-38. PubMed ID: 27033426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacy patronage and service utilization: Associations with patient sociodemographic and health characteristics.
    Patterson JA; Holdford DA
    J Am Pharm Assoc (2003); 2019; 59(5):660-669.e2. PubMed ID: 31311757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoting Community Pharmacy Practice for Chronic Obstructive Pulmonary Disease (COPD) Management: A Systematic Review and Logic Model.
    Hu Y; Yao D; Ung COL; Hu H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1863-1875. PubMed ID: 32821091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of unmet demand for pharmacists: a survey of rural community pharmacies in Wisconsin.
    Gadkari AS; Mott DA; Kreling DH; Bonnarens JK
    J Am Pharm Assoc (2003); 2008; 48(5):598-609. PubMed ID: 18826899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of community pharmacist administration of long-acting injectable antipsychotic medications.
    Black RM; Hughes TD; Ma F; Hudzik AA; Shepherd G; Ferreri S; Ozawa S
    J Am Pharm Assoc (2003); 2023; 63(3):742-750.e3. PubMed ID: 36740528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient satisfaction with pharmacist-administered Mantoux tuberculin skin test in a community-based pharmacy setting.
    Goode JV; Upshur R; Grimes MB; Nadpara P
    J Am Pharm Assoc (2003); 2019; 59(4S):S77-S80.e2. PubMed ID: 31203013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilisation of the PRECEDE-PROCEED model in community pharmacy for health needs assessment: A narrative review.
    Handyside L; Warren R; Devine S; Drovandi A
    Res Social Adm Pharm; 2021 Feb; 17(2):292-299. PubMed ID: 32253124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.